{"transactions":[{"id":2526340,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2021-11-03T16:16:00.000Z","date":"2021-11-02","kind":"tax_withholding","acquired":false,"shares":62,"price":1.98,"value":122.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 11/01/2021."}],"balance_after":15136,"source":{"system":"sec-edgar","filing":"0001104659-21-133652","document":"tm2131814-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465921133652/tm2131814-2_4seq1.xml","form_type":"4"}},{"id":2548966,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2021-10-05T18:40:11.000Z","date":"2021-10-04","kind":"tax_withholding","acquired":false,"shares":62,"price":2.01,"value":124.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 10/01/2021."}],"balance_after":15198,"source":{"system":"sec-edgar","filing":"0001104659-21-123266","document":"tm2129310d2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465921123266/tm2129310d2_4seq1.xml","form_type":"4"}},{"id":2579273,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2021-09-03T16:15:47.000Z","date":"2021-09-02","kind":"tax_withholding","acquired":false,"shares":61,"price":1.81,"value":110.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 09/01/2021."}],"balance_after":15260,"source":{"system":"sec-edgar","filing":"0001104659-21-112937","document":"tm2126978-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465921112937/tm2126978-1_4seq1.xml","form_type":"4"}},{"id":2614881,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2021-08-04T17:45:54.000Z","date":"2021-08-03","kind":"tax_withholding","acquired":false,"shares":63,"price":2.4,"value":151.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 08/01/2021."}],"balance_after":15321,"source":{"system":"sec-edgar","filing":"0001104659-21-100197","document":"tm2124160d2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465921100197/tm2124160d2_4seq1.xml","form_type":"4"}},{"id":2641271,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2021-07-06T16:31:18.000Z","date":"2021-07-02","kind":"tax_withholding","acquired":false,"shares":154,"price":3.7,"value":569.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 07/01/2021."}],"balance_after":15384,"source":{"system":"sec-edgar","filing":"0001104659-21-089443","document":"tm2121558d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465921089443/tm2121558d2_4.xml","form_type":"4"}},{"id":2679367,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2021-06-07T17:01:38.000Z","date":"2021-06-04","kind":"tax_withholding","acquired":false,"shares":155,"price":4.19,"value":649.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 06/01/2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.19 to $4.39, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":15538,"source":{"system":"sec-edgar","filing":"0001104659-21-077763","document":"tm2119042d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465921077763/tm2119042d1_4seq1.xml","form_type":"4"}},{"id":2727310,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2021-05-05T21:56:52.000Z","date":"2021-05-04","kind":"tax_withholding","acquired":false,"shares":191,"price":4.13,"value":788.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 05/01/2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.12 to $4.37, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":15693,"source":{"system":"sec-edgar","filing":"0001104659-21-061946","document":"tm2115347d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465921061946/tm2115347d1_4.xml","form_type":"4"}},{"id":2752128,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2021-04-09T16:15:52.000Z","date":"2021-04-08","kind":"tax_withholding","acquired":false,"shares":192,"price":4.94,"value":948.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 04/01/2021."}],"balance_after":15884,"source":{"system":"sec-edgar","filing":"0001104659-21-048712","document":"tm2112624-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465921048712/tm2112624-1_4seq1.xml","form_type":"4"}},{"id":2806265,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2021-03-05T16:31:08.000Z","date":"2021-03-03","kind":"tax_withholding","acquired":false,"shares":192,"price":5.46,"value":1048.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 03/01/2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.46 to $5.51, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":16076,"source":{"system":"sec-edgar","filing":"0001104659-21-032763","document":"tm218853-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465921032763/tm218853-1_4.xml","form_type":"4"}},{"id":2881926,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-03T21:53:44.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2022, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":10000,"derivative":{"exercise_price":6.46,"expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-21-011852","document":"tm215262-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465921011852/tm215262-10_4seq1.xml","form_type":"4"}},{"id":2881925,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2021-02-03T21:53:44.000Z","date":"2021-02-02","kind":"tax_withholding","acquired":false,"shares":988,"price":6.34,"value":6263.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 02/01/2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.32 to $6.34, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":16268,"source":{"system":"sec-edgar","filing":"0001104659-21-011852","document":"tm215262-10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465921011852/tm215262-10_4seq1.xml","form_type":"4"}},{"id":2920639,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2021-01-05T16:15:25.000Z","date":"2021-01-04","kind":"tax_withholding","acquired":false,"shares":115,"price":4.85,"value":557.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 01/01/2021."}],"balance_after":17256,"source":{"system":"sec-edgar","filing":"0001104659-21-000927","document":"tm211689-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465921000927/tm211689-1_4seq1.xml","form_type":"4"}},{"id":2953464,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2020-12-08T20:17:42.000Z","date":"2020-12-07","kind":"tax_withholding","acquired":false,"shares":91,"price":3.76,"value":342.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 12/01/2020."}],"balance_after":17371,"source":{"system":"sec-edgar","filing":"0001104659-20-133326","document":"tm2038041-4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465920133326/tm2038041-4_4.xml","form_type":"4"}},{"id":2994855,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2020-11-03T16:15:57.000Z","date":"2020-11-02","kind":"tax_withholding","acquired":false,"shares":96,"price":3.51,"value":336.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 11/01/2020."}],"balance_after":17462,"source":{"system":"sec-edgar","filing":"0001104659-20-120954","document":"tm2034888d3_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465920120954/tm2034888d3_form4.xml","form_type":"4"}},{"id":3013355,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2020-10-05T17:56:12.000Z","date":"2020-10-02","kind":"tax_withholding","acquired":false,"shares":98,"price":3.88,"value":380.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 10/01/2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.88 to $3.99, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":17558,"source":{"system":"sec-edgar","filing":"0001104659-20-112300","document":"tm2032523-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465920112300/tm2032523-1_4.xml","form_type":"4"}},{"id":3039326,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2020-09-03T17:31:11.000Z","date":"2020-09-02","kind":"tax_withholding","acquired":false,"shares":97,"price":3.94,"value":382.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 09/01/2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.93 to $3.94, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":17656,"source":{"system":"sec-edgar","filing":"0001104659-20-102299","document":"tm2030216d3_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465920102299/tm2030216d3_form4.xml","form_type":"4"}},{"id":3067523,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2020-08-05T17:11:41.000Z","date":"2020-08-04","kind":"tax_withholding","acquired":false,"shares":92,"price":4.11,"value":378.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 08/01/2020."}],"balance_after":17753,"source":{"system":"sec-edgar","filing":"0001104659-20-090917","document":"tm2026743-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465920090917/tm2026743-1_4.xml","form_type":"4"}},{"id":3088905,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2020-07-06T16:15:21.000Z","date":"2020-07-02","kind":"tax_withholding","acquired":false,"shares":94,"price":4.82,"value":453.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 07/01/2020."}],"balance_after":17845,"source":{"system":"sec-edgar","filing":"0001104659-20-081219","document":"tm2024119-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465920081219/tm2024119-1_4.xml","form_type":"4"}},{"id":3122142,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2020-06-04T16:17:29.000Z","date":"2020-06-03","kind":"tax_withholding","acquired":false,"shares":94,"price":5.11,"value":480.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 06/01/2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.11 to $5.1775, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":17939,"source":{"system":"sec-edgar","filing":"0001104659-20-069823","document":"tm2021837-2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465920069823/tm2021837-2_4.xml","form_type":"4"}},{"id":3159570,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2020-05-06T16:31:26.000Z","date":"2020-05-05","kind":"tax_withholding","acquired":false,"shares":113,"price":5.1,"value":576.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 05/01/2020."}],"balance_after":18033,"source":{"system":"sec-edgar","filing":"0001104659-20-057472","document":"tm2018856d3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465920057472/tm2018856d3_4.xml","form_type":"4"}},{"id":3183476,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2020-04-03T17:56:15.000Z","date":"2020-04-02","kind":"tax_withholding","acquired":false,"shares":122,"price":4.97,"value":606.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 04/01/2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.96 to $5.09, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":18146,"source":{"system":"sec-edgar","filing":"0001104659-20-043264","document":"tm2014998d4_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465920043264/tm2014998d4_form4.xml","form_type":"4"}},{"id":3217884,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2020-03-10T19:13:11.000Z","date":"2020-03-09","kind":"tax_withholding","acquired":false,"shares":130,"price":5,"value":650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 03/01/2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.01, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":18268,"source":{"system":"sec-edgar","filing":"0001104659-20-031498","document":"tm2012338d3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465920031498/tm2012338d3_4.xml","form_type":"4"}},{"id":3263451,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-19T16:31:00.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2021, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":7500,"derivative":{"exercise_price":6.55,"expiration_date":"2030-02-14","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001104659-20-022841","document":"tm209305-2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465920022841/tm209305-2_4.xml","form_type":"4"}},{"id":3263450,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2020-02-19T16:31:00.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on February 1, 2021, and the remaining balance will vest monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":18398,"source":{"system":"sec-edgar","filing":"0001104659-20-022841","document":"tm209305-2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465920022841/tm209305-2_4.xml","form_type":"4"}},{"id":3288898,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2020-02-05T17:02:56.000Z","date":"2020-02-04","kind":"tax_withholding","acquired":false,"shares":109,"price":6,"value":654.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 02/01/2020."}],"balance_after":10898,"source":{"system":"sec-edgar","filing":"0001104659-20-011324","document":"tm206871d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465920011324/tm206871d2_4.xml","form_type":"4"}},{"id":3318540,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2020-01-06T17:48:03.000Z","date":"2020-01-03","kind":"tax_withholding","acquired":false,"shares":119,"price":9.52,"value":1132.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 01/01/2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.3537 to $9.52, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":11007,"source":{"system":"sec-edgar","filing":"0001104659-20-001638","document":"tm201302-3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465920001638/tm201302-3_4.xml","form_type":"4"}},{"id":3333898,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2019-12-20T17:28:05.000Z","date":"2019-12-18","kind":"tax_withholding","acquired":false,"shares":101,"price":7.46,"value":753.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 12/01/2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.46 to $7.47, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":11126,"source":{"system":"sec-edgar","filing":"0001104659-19-075133","document":"tm1926709d3_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465919075133/tm1926709d3_form4.xml","form_type":"4"}},{"id":3377682,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2019-11-07T16:15:44.000Z","date":"2019-11-05","kind":"tax_withholding","acquired":false,"shares":107,"price":3.85,"value":411.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 11/01/2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.85 to $3.92, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":11227,"source":{"system":"sec-edgar","filing":"0001104659-19-061121","document":"tm1922166-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000110465919061121/tm1922166-1_4.xml","form_type":"4"}},{"id":3394346,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2019-10-11T16:06:05.000Z","date":"2019-10-09","kind":"tax_withholding","acquired":false,"shares":184,"price":3.12,"value":574.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 09/01/2019 and 10/01/2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.92 to $3.39, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Effective as of 08/30/2019, the Issuer effected a 1-for-15 reverse split of its common stock. The number of shares reflects the reverse stock split."}],"balance_after":11334,"source":{"system":"sec-edgar","filing":"0001144204-19-048121","document":"tv530954_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000114420419048121/tv530954_4.xml","form_type":"4"}},{"id":3444647,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2019-08-07T19:21:05.000Z","date":"2019-08-06","kind":"tax_withholding","acquired":false,"shares":1641,"price":0.21,"value":344.61,"ownership":{"direct":true},"balance_after":172783,"source":{"system":"sec-edgar","filing":"0001144204-19-038332","document":"tv527075_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000114420419038332/tv527075_4.xml","form_type":"4"}},{"id":3461925,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2019-07-15T20:37:34.000Z","date":"2019-07-15","kind":"sale","acquired":false,"shares":6350,"price":0.233,"value":1479.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 07/10/2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.227 to $0.2403, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4."}],"balance_after":174424,"source":{"system":"sec-edgar","filing":"0001144204-19-034762","document":"tv525228_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000114420419034762/tv525228_4.xml","form_type":"4"}},{"id":3461924,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2019-07-15T20:37:34.000Z","date":"2019-07-12","kind":"sale","acquired":false,"shares":6350,"price":0.2356,"value":1496.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 07/10/2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.2257 to $0.24, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."}],"balance_after":180774,"source":{"system":"sec-edgar","filing":"0001144204-19-034762","document":"tv525228_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000114420419034762/tv525228_4.xml","form_type":"4"}},{"id":3461923,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2019-07-15T20:37:34.000Z","date":"2019-07-11","kind":"sale","acquired":false,"shares":6349,"price":0.2406,"value":1527.5694,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 07/10/2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.24 to $0.245, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":187124,"source":{"system":"sec-edgar","filing":"0001144204-19-034762","document":"tv525228_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000114420419034762/tv525228_4.xml","form_type":"4"}},{"id":3674444,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-05T16:35:11.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2020, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":50000,"derivative":{"exercise_price":0.48,"expiration_date":"2029-02-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001144204-19-005040","document":"tv512440_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000114420419005040/tv512440_form4.xml","form_type":"4"}},{"id":3868726,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2018-07-12T16:54:04.000Z","date":"2018-07-10","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The restrictions will vest as to one-third (1/3) of the shares on July 10, 2019, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":193473,"source":{"system":"sec-edgar","filing":"0001144204-18-038184","document":"tv498476_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000114420418038184/tv498476_4.xml","form_type":"4"}},{"id":4023982,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Stock Option (right to buy)","published_at":"2018-03-01T16:18:45.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 28, 2019, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":15000,"derivative":{"exercise_price":0.57,"expiration_date":"2028-02-28","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001144204-18-012243","document":"tv487520_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000114420418012243/tv487520_4.xml","form_type":"4"}},{"id":4112396,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2018-01-03T16:07:07.000Z","date":"2017-12-29","kind":"other","acquired":true,"shares":6722,"price":1.01,"value":6789.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Issuer's Employee Stock Purchase Plan on December 29, 2017 in a transaction exempt under Rule 16b-3(c)."}],"balance_after":18473,"source":{"system":"sec-edgar","filing":"0001144204-18-000495","document":"tv482537_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000114420418000495/tv482537_4.xml","form_type":"4"}},{"id":4274625,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Stock Option (right to buy)","published_at":"2017-06-22T16:25:33.000Z","date":"2017-06-21","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on June 21, 2018, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":15000,"derivative":{"exercise_price":1.35,"expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001144204-17-033638","document":"v469457_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000114420417033638/v469457_4.xml","form_type":"4"}},{"id":4464148,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":133884,"kind":"person","name":"Mann Brenda","position":1,"cik":"0001668858","reported_name":"Mann Brenda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research & Development"}}],"security":"Common Stock","published_at":"2017-02-07T16:16:56.000Z","date":"2017-02-06","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan.  The restrictions will vest as to one-third (1/3) of the shares on February 6, 2018, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":11751,"source":{"system":"sec-edgar","filing":"0001144204-17-006505","document":"v458601_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668858/000114420417006505/v458601_4.xml","form_type":"4"}}]}